A multiplexed immunocapture liquid chromatography tandem mass spectrometry assay for the simultaneous measurement of myostatin and GDF-11 in rat serum using an automated sample preparation platform.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Analytica Chimica Acta

• Publication date

  2017-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.aca.2017.04.028PMID 28599707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.

  2016cited by this paper
• Hybridizing LBA with LC-MS/MS: the new norm for biologics quantification.

  2016cited by this paper
• Strategies for improving sensitivity and selectivity for the quantitation of biotherapeutics in biological matrix using LC-MS/MS

  2015cited by this paper
• Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC-MS/MS approach: Assay development, validation, and a case study.

  2015cited by this paper
• Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle

  2014cited by this paper
• Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review

  2014cited by this paper
• Bioanalytical LC-MS/MS of protein-based biopharmaceuticals.

  2013cited by this paper
• Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.

  2013cited by this paper
• Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.

  2012cited by this paper
• Endocrine and clinical correlates of myostatin serum concentration in men--the STRAMBO study.

  2012cited by this paper
• Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men.

  2011cited by this paper
• Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration.

  2009cited by this paper
• Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs.

  2009cited by this paper
• Smad2 and 3 transcription factors control muscle mass in adulthood.

  2009cited by this paper
• Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

  2008cited by this paper
• Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry.

  2008cited by this paper
• Targeting myostatin for therapies against muscle-wasting disorders.

  2008cited by this paper
• The myostatin gene: physiology and pharmacological relevance.

  2007cited by this paper
• Regulation of muscle mass by myostatin.

  2004cited by this paper
• Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis

  1999cited by this paper
• Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis.

  1999cited by this paper
• Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member

  1997cited by this paper
• LC/MS and LC/MS/MS determination of protein tryptic digests

  1990cited by this paper
• GROWTH PATTERNS OF MUSCLE. FAT AND BONE. AND CARCASS COMPOSITION OF DOUBLE MUSCLED AND NORMAL CATTLE

  1985cited by this paper

• Bioorthogonal Chemistry: Enzyme Immune and Protein Capture for Enhanced LC-MS Bioanalysis.

  2024cites this paper
• Simultaneous quantification of the 22-kDa isoforms of human growth hormone 1 and 2 in human plasma by multiplexed immunocapture and LC-MS/MS.

  2023cites this paper
• Low-density lipoproteins, resveratrol and quercetin as alternative additives to improve boar semen cooling.

  2023cites this paper
• Proximity labeling for investigating protein-protein interactions.

  2022cites this paper
• Strategies for mass spectrometry-based phosphoproteomics using isobaric tagging

  2021cites this paper
• Advances in quantitative high‐throughput phosphoproteomics with sample multiplexing

  2021cites this paper
• Improved Ultra-performance liquid chromatographic method for simultaneous determination of five gout-related metabolites in human serum.

  2020cites this paper
• Bioanalysis of biological matrix samples using liquid chromatography–tandem mass spectrometry detection

  2020cites this paper
• Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.

  2019cites this paper
• A sensitive antibody-free 2D-LC-MS/MS assay for the quantitation of myostatin in the serum of different species.

  2019cites this paper
• Opportunities and challenges for hybrid immunoaffinity LC–MS approach for quantitative analysis of protein biomarkers

  2018cites this paper
• ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates

  2018cites this paper
• Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.

  2018cites this paper